"Over 98%" Of OTC Ads Breach WHO/EU Rules

25 September 1994

More than 98% of print advertising of over-the-counter health care products fails to follow international rules and guidelines aimed at protecting the consumer, says a report published this month by the International Organization of Consumers Unions.

The study, A searching Look At Advertising, found that out of 183 print ads from 11 countries, only three fully complied with the guidelines and rules of the World Health organization and the European Union. "We believe this is a significant cause for concern," say the report's authors, adding that while they hope governments will take note and seek to improve procedures, the situation will not improve overnight, and "there is a need to keep the activities of the drug companies under scrutiny."

The international guidelines concerned are the EU Directive on Advertising of Medicinal Products (1992) and the WHO Ethical Criteria on the promotion of Medicinal Products (1988). The WHO Criteria are not legally enforced, and the EU Directive became law after the ads used in the sample were collected, but the IOCU says it is still possible to conclude that a gap exists between the current advertising of OTCs and these standards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight